Nature’s Sunshine Products (NASDAQ:NATR) Major Shareholder Prescott Group Capital Managem Purchases 4,513 Shares

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) major shareholder Prescott Group Capital Managem acquired 4,513 shares of the stock in a transaction dated Thursday, August 6th. The shares were bought at an average price of $16.57 per share, with a total value of $74,780.41. Following the completion of the transaction, the insider directly owned 1,787,610 shares of the company’s stock, valued at $29,620,697.70. The trade was a 0.25% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Prescott Group Capital Managem also recently made the following trade(s):

• On Monday, August 10th, Prescott Group Capital Managem bought 40,876 shares of Nature’s Sunshine Products stock. The stock was bought at an average price of $15.84 per share, for a total transaction of $647,475.84.
• On Friday, August 7th, Prescott Group Capital Managem bought 96,000 shares of Nature’s Sunshine Products stock. The shares were purchased at an average cost of $16.63 per share, with a total value of $1,596,480.00.

Nature’s Sunshine Products Stock Down 3.7%

Nature’s Sunshine Products stock traded down $0.61 during mid-day trading on Monday, hitting $15.77. 426,791 shares of the stock were exchanged, compared to its average volume of 139,474. Nature’s Sunshine Products, Inc. has a 12 month low of $12.97 and a 12 month high of $28.14. The firm’s fifty day simple moving average is $20.52 and its two-hundred day simple moving average is $23.44. The stock has a market capitalization of $277.55 million, a price-to-earnings ratio of 15.61 and a beta of 0.88.

Nature’s Sunshine Products (NASDAQ:NATR) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.21 EPS for the quarter, missing analysts’ consensus estimates of $0.27 by ($0.06). Nature’s Sunshine Products had a net margin of 3.68% and a return on equity of 12.88%. The firm had revenue of $116.99 million during the quarter, compared to the consensus estimate of $123.70 million.

Institutional Investors Weigh In On Nature’s Sunshine Products

A number of large investors have recently bought and sold shares of NATR. BlackRock Inc. bought a new stake in Nature’s Sunshine Products in the second quarter valued at $21,561,000. Dimensional Fund Advisors LP boosted its position in shares of Nature’s Sunshine Products by 2.2% during the 3rd quarter. Dimensional Fund Advisors LP now owns 913,791 shares of the company’s stock worth $14,181,000 after purchasing an additional 20,037 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Nature’s Sunshine Products by 15.3% during the 3rd quarter. Vanguard Group Inc. now owns 803,104 shares of the company’s stock worth $12,464,000 after purchasing an additional 106,688 shares in the last quarter. Kennedy Capital Management LLC grew its stake in shares of Nature’s Sunshine Products by 14.6% in the 3rd quarter. Kennedy Capital Management LLC now owns 675,764 shares of the company’s stock valued at $10,488,000 after buying an additional 86,128 shares during the period. Finally, Renaissance Technologies LLC grew its stake in shares of Nature’s Sunshine Products by 1.5% in the 1st quarter. Renaissance Technologies LLC now owns 531,924 shares of the company’s stock valued at $12,761,000 after buying an additional 7,827 shares during the period. 79.40% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have weighed in on NATR shares. Canaccord Genuity Group decreased their price target on Nature’s Sunshine Products from $37.00 to $36.00 and set a “buy” rating for the company in a report on Thursday, July 30th. Weiss Ratings downgraded Nature’s Sunshine Products from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 9th. Wall Street Zen lowered Nature’s Sunshine Products from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Finally, DA Davidson lowered their target price on Nature’s Sunshine Products from $33.00 to $25.00 and set a “buy” rating for the company in a report on Monday. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Nature’s Sunshine Products presently has a consensus rating of “Moderate Buy” and an average target price of $30.50.

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.